Skip to content
WeighLab
Menu

Head-to-head · Cost-Efficiency Index

Roen Rx vs Better MedSpa

Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.

Better valueGrade C · #454

Roen Rx

Cost-first shoppers who want insured shoppers chasing a low brand-name copay via RoenRx's insurance coordination, with a compounded fallback.

Visit Roen Rx
VS
Grade C · #456

Better MedSpa

Shoppers who want an in-person Chicago/Illinois med spa GLP-1 program and are comparing the real month-to-month rate, not the quarterly-discounted headline.

Visit Better MedSpa

The verdict

Too close to callGrade C vs C

Roen Rx and Better MedSpa tie on the Cost-Efficiency Index at 46/100, so neither wins outright on the numbers. For most shoppers we'd start with Roen Rx (ranked #454, a hair above #456) — Cost-first shoppers who want insured shoppers chasing a low brand-name copay via RoenRx's insurance coordination, with a compounded fallback. But Better MedSpa is a genuine coin-flip alternative here.

Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Roen Rx.

Factor by factor

Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.

Normalized Cost/Month

25
22

Price Transparency

64
30

Nationwide Access

24
42

Formulation Options

79
82

Clinical Oversight

62
77

Contract Flexibility

33
47

Pricing, coverage & formulary

The disclosed facts behind the scores. Lower price wins its row (teal).

SpecRoen RxBetter MedSpa
Cost-Efficiency Index46/10046/100
Semaglutide / mo$151/mo (starting dose, 3-month plan, plus a separate fee, compounded)$300/mo (compounded)
Tirzepatide / mo$216/mo (starting dose, plus a separate fee, compounded)$400/mo (compounded)
Semaglutide / yr (modeled)$1,812$3,600
Tirzepatide / yr (modeled)$2,592$4,800
CoverageCoverage not published1 state
Oral / sublingualNoYes
Brand-name accessYesCompounded only
Rank here#454#456

Roen Rx

46/100

Where the value is

  • Insurance coordination path can bring brand-name GLP-1s down to as low as $25/mo for covered patients
  • Both compounded and brand-name (Ozempic, Wegovy, Zepbound, Mounjaro) options on one platform
  • Explicitly serves all 50 states and DC

The tradeoffs

  • The advertised LegitScript badge on the homepage is literally commented out in the page's HTML source and never renders on the live site — despite being present in source, it is not a real, visible certification a visitor sees
  • Medication cost and membership fee are billed separately; the membership's regular (non-promotional) monthly price is never disclosed anywhere checked, only the '$39 first month' discount
Visit Roen Rx

Full Roen Rx review →

Regulatory note: the FDA issued a warning letter to Roen Health, Inc. dba RoenRx in June 2026. We still list and link to Roen Rx; you should know the letter is on the public record before you decide.

Better MedSpa

46/100

Where the value is

  • Named medical director, Dr. Brett Brechner, DO, publicly credited on-site
  • Real dollar pricing published on the memberships page for both semaglutide and tirzepatide, broken out by 1-month vs. 3-month commitment
  • Serves Illinois statewide via telehealth with an in-person Lincoln Park, Chicago location

The tradeoffs

  • The treatment page's advertised 'Starting at $290' is the 3-month PREPAID rate, not the standing price -- month-to-month semaglutide is actually $300/month
  • No pharmacy name, LegitScript certification, or lab/COA testing disclosure found anywhere on the site
Visit Better MedSpa

Full Better MedSpa review →

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.

Keep comparing

← All head-to-head comparisons